46.70
price up icon6.11%   2.69
after-market 시간 외 거래: 46.70
loading
전일 마감가:
$44.01
열려 있는:
$43.83
하루 거래량:
1.23M
Relative Volume:
1.28
시가총액:
$3.69B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-62.27
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
+18.89%
1개월 성능:
+27.14%
6개월 성능:
+71.94%
1년 성능:
+17.96%
1일 변동 폭
Value
$43.24
$46.93
1주일 범위
Value
$37.98
$46.93
52주 변동 폭
Value
$22.61
$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name
명칭
Veracyte Inc
Name
전화
(650) 243-6300
Name
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
직원
824
Name
트위터
@veracyte
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
VCYT's Discussions on Twitter

VCYT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
VCYT
Veracyte Inc
46.70 3.48B 399.58M -54.04M 40.13M -0.75
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
586.07 220.72B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
226.98 160.62B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
752.14 57.96B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
153.60 42.88B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
228.18 38.30B 15.90B 1.28B 2.21B 7.2842

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-20 개시 Canaccord Genuity Hold
2025-03-20 개시 Craig Hallum Buy
2024-12-05 다운그레이드 Goldman Buy → Neutral
2024-11-15 개시 Wolfe Research Outperform
2024-10-16 개시 UBS Buy
2024-10-10 개시 Guggenheim Buy
2024-02-23 재확인 Needham Buy
2023-01-18 다운그레이드 Raymond James Outperform → Mkt Perform
2023-01-05 개시 Scotiabank Sector Outperform
2022-01-07 개시 Stephens Overweight
2021-11-18 재개 Goldman Buy
2021-06-15 개시 Raymond James Outperform
2021-02-18 재개 Needham Buy
2021-01-28 개시 Truist Buy
2020-11-10 개시 KeyBanc Capital Markets Sector Weight
2020-09-09 개시 Morgan Stanley Underweight
2019-07-31 개시 Lake Street Buy
2019-07-02 개시 Needham Buy
2018-11-29 다운그레이드 Janney Buy → Neutral
2018-10-31 업그레이드 Janney Neutral → Buy
2017-11-07 다운그레이드 Janney Buy → Neutral
2017-11-07 다운그레이드 Piper Jaffray Overweight → Neutral
2017-08-31 재개 BTIG Research Buy
2016-11-14 재개 Leerink Partners Outperform
2015-12-18 개시 Cantor Fitzgerald Buy
2015-06-11 재확인 Leerink Partners Outperform
2013-11-26 개시 William Blair Outperform
모두보기

Veracyte Inc 주식(VCYT)의 최신 뉴스

pulisher
Nov 23, 2025

Veracyte Stock Soars Amid Strong Earnings and New Price Targets - timothysykes.com

Nov 23, 2025
pulisher
Nov 22, 2025

Veracyte Stock Surges Amid Investor Conferences and Robust Earnings - StocksToTrade

Nov 22, 2025
pulisher
Nov 22, 2025

Is Veracyte Inc a good long term investmentMoving Average Crossovers & AI-Based Insights for Consistent Profits - earlytimes.in

Nov 22, 2025
pulisher
Nov 22, 2025

Veracyte Stock Soars Amid Revenue and EPS Surprises - timothysykes.com

Nov 22, 2025
pulisher
Nov 22, 2025

Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

Nov 22, 2025
pulisher
Nov 21, 2025

Insider Sell: Jens Holstein Sells 10,000 Shares of Veracyte Inc (VCYT) - GuruFocus

Nov 21, 2025
pulisher
Nov 21, 2025

Veracyte Director Jens Holstein Sells 10,000 Shares - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

Dir Holstein Sells 10,000 ($423.6K) Of Veracyte Inc [VCYT] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Will Veracyte Inc. (12V) stock sustain bullish trend into 2025Earnings Overview Summary & Safe Entry Point Identification - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can Veracyte Inc. (12V) stock surprise markets with earningsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Veracyte at Stephens Conference: Strategic Growth and Expansion By Investing.com - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Stephens Conference: Strategic Growth and Expansion - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Jefferies London: Strategic Expansion and Growth By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Jefferies London: Strategic Expansion and Growth - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Veracyte Inc. stock gain from government policiesShort Setup & Weekly High Conviction Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Veracyte Inc. (12V) stock profit from fiscal stimulus2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Veracyte Inc. (12V) stock sustain breakout momentumRisk Management & Daily Entry Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Veracyte Inc. stock performs in interest rate cyclesPortfolio Return Summary & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to read the order book for Veracyte Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tools to assess Veracyte Inc.’s risk profileEarnings Beat & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Veracyte Inc. (12V) stock cheap vs fundamentalsGap Down & Verified Momentum Stock Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Heatmap analysis for Veracyte Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

Veracyte Inc (VCYT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research DGX
$190.58
price down icon 0.35%
diagnostics_research LH
$265.31
price down icon 0.12%
diagnostics_research WAT
$399.54
price up icon 1.41%
diagnostics_research MTD
$1,470.14
price up icon 1.22%
$238.58
price up icon 3.45%
diagnostics_research IQV
$228.18
price up icon 1.46%
자본화:     |  볼륨(24시간):